Valuation Abbott Laboratories London S.E.

Stocks

Real-time Estimate Cboe BZX 10:36:03 17/09/26 pm AEST			5-day change	1st Jan Change
104.82 ^USD	+1.87%		-2.75%	-18.21%

15/09	Abbott Announces First Canadian Use of Volt Pulsed Field Ablation System to Treat Atrial Fibrillation	CI
15/09	Abbott Laboratories to Pay $385 Million to Settle Infant Formula Allegations	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	241,365	191,427	191,088	196,184	217,859	177,122	-	-
Change	-	-20.69%	-0.18%	2.67%	11.05%	-18.7%	-	-
Enterprise Value (EV) ¹	249,166	198,318	198,871	202,693	222,266	201,061	198,079	194,389
Change	-	-20.41%	0.28%	1.92%	9.66%	-9.54%	-1.48%	-1.86%
P/E	35.7x	28.1x	33.8x	14.8x	33.7x	29x	22.5x	20x
PBR	6.93x	5.2x	4.94x	4.11x	4.18x	3.7x	3.54x	3.36x
PEG	-	-36.9x	-2x	0x	-0.7x	-5.67x	0.8x	1.6x
Capitalization / Revenue	5.6x	4.39x	4.76x	4.68x	4.91x	3.53x	3.25x	3.04x
EV / Revenue	5.78x	4.54x	4.96x	4.83x	5.01x	4x	3.63x	3.34x
EV / EBITDA	19.4x	15.9x	19.5x	19.1x	18.9x	15.5x	13.7x	12.3x
EV / EBIT	22x	17.7x	22.3x	21.8x	21.6x	17.2x	15.2x	13.6x
EV / FCF	28.8x	25.4x	39.3x	31.9x	30.1x	26.6x	22.2x	20.3x
FCF Yield	3.47%	3.94%	2.54%	3.13%	3.33%	3.75%	4.5%	4.93%
Dividend per Share ²	1.82	1.92	2.08	2.24	2.4	2.571	2.741	2.896
Rate of return	1.29%	1.75%	1.89%	1.98%	1.92%	2.51%	2.68%	2.83%
EPS ²	3.94	3.91	3.26	7.64	3.72	3.53	4.553	5.106
Distribution rate	46.2%	49.1%	63.8%	29.3%	64.5%	72.8%	60.2%	56.7%
Net sales ¹	43,075	43,653	40,109	41,950	44,328	50,204	54,528	58,247
EBITDA ¹	12,815	12,485	10,188	10,635	11,735	12,989	14,491	15,854
EBIT ¹	11,324	11,231	8,911	9,295	10,301	11,719	13,021	14,319
Net income ¹	7,071	6,933	5,723	13,402	6,524	6,303	7,978	8,906
Net Debt ¹	7,801	6,891	7,783	6,509	4,407	23,939	20,957	17,267
Reference price ²	140.74	109.79	110.07	113.11	125.29	102.36	102.36	102.36
Nbr of stocks (in thousands)	1,714,968	1,743,574	1,736,059	1,734,455	1,738,834	1,730,383	-	-
Announcement Date	26/1/22	25/1/23	24/1/24	22/1/25	22/1/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ABBOTT LABORATORIES	29x	4x	15.48x	2.51%	177B
MEDTRONIC PLC	19.59x	3.57x	12.77x	3.04%	118B
CENCORA, INC.	17.44x	0.2x	12.75x	0.75%	60.78B
BECTON, DICKINSON AND COMPANY	35.04x	3.4x	11.62x	2.16%	49.53B
HOYA CORPORATION	27.4x	6.74x	17.36x	1.46%	48.29B
DEXCOM, INC.	35.01x	6.16x	19.33x	-.--%	32.96B
MEDLINE INC.	42.59x	1.25x	11.58x	0.22%	28.94B
WEST PHARMACEUTICAL SERVICES, INC.	42.22x	7.4x	26.55x	0.25%	25.48B
SARTORIUS STEDIM BIOTECH	49.45x	6.68x	21.46x	0.43%	21.77B
Average	33.08x	4.38x	16.54x	1.2%	62.59B
Weighted average by Cap.	28.61x	3.93x	15.19x	1.86%